Cargando…
Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer
IKBKE is an oncogene in triple-negative breast cancer (TNBC), and we demonstrate that IKBKE small interfering RNA (siRNA) inhibits the proliferation, migration, and invasion of TNBC cells. Despite the recent success of siRNA therapeutics targeting to the liver, there still remains a great challenge...
Autores principales: | Zhao, Zhen, Li, Yuanke, Liu, Hao, Jain, Akshay, Patel, Pratikkumar Vinodchandra, Cheng, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439402/ https://www.ncbi.nlm.nih.gov/pubmed/32832636 http://dx.doi.org/10.1126/sciadv.abb0616 |
Ejemplares similares
-
Development of a Biocompatible Copolymer Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer
por: Zhao, Zhen, et al.
Publicado: (2019) -
Cyclic Peptide-Gadolinium Nanocomplexes as siRNA Delivery Tools
por: Nasrolahi Shirazi, Amir, et al.
Publicado: (2021) -
Design of a Multicomponent Peptide-Woven Nanocomplex for Delivery of siRNA
por: Jun, Eunsung, et al.
Publicado: (2015) -
Peptide-Based siRNA Nanocomplexes Targeting Hepatic Stellate Cells
por: Lin, Chien-Yu, et al.
Publicado: (2023) -
Novel fusion peptide‐mediated siRNA delivery using self‐assembled nanocomplex
por: Ryu, Yeong Chae, et al.
Publicado: (2021)